Lamivudine Tablet, Film Coated
Product Images NDC 60505-3250

2 FDA label images from Apotex Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 60505-3250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure.jpg (Chemical Structure)

Chemical-structure.jpg (Chemical Structure)
Chemical structure of lamivudine as seen in the image, including its molecular components and a methanol (CH3OH) solvate notation (0.2 CH3OH).*
FDA Label Image

Container-label.jpg (Container Label)

Container-label.jpg (Container Label)
Label for Lamivudine Tablets (HBV) 100 mg film-coated tablets in a package of 60 tablets. Manufactured by Apotex Inc. and labeled for Apotex Corp. The label includes storage instructions, dosage reference, and a barcode with product NDC 60505-3250-6.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.